These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
649 related articles for article (PubMed ID: 19557159)
1. Epstein-barr virus latency in B cells leads to epigenetic repression and CpG methylation of the tumour suppressor gene Bim. Paschos K; Smith P; Anderton E; Middeldorp JM; White RE; Allday MJ PLoS Pathog; 2009 Jun; 5(6):e1000492. PubMed ID: 19557159 [TBL] [Abstract][Full Text] [Related]
2. Two Epstein-Barr virus (EBV) oncoproteins cooperate to repress expression of the proapoptotic tumour-suppressor Bim: clues to the pathogenesis of Burkitt's lymphoma. Anderton E; Yee J; Smith P; Crook T; White RE; Allday MJ Oncogene; 2008 Jan; 27(4):421-33. PubMed ID: 17653091 [TBL] [Abstract][Full Text] [Related]
3. BIM promoter directly targeted by EBNA3C in polycomb-mediated repression by EBV. Paschos K; Parker GA; Watanatanasup E; White RE; Allday MJ Nucleic Acids Res; 2012 Aug; 40(15):7233-46. PubMed ID: 22584624 [TBL] [Abstract][Full Text] [Related]
4. The 5' regulatory sequences of active miR-146a promoters are hypomethylated and associated with euchromatic histone modification marks in B lymphoid cells. Szenthe K; Koroknai A; Banati F; Bathori Z; Lozsa R; Burgyan J; Wolf H; Salamon D; Nagy K; Niller HH; Minarovits J Biochem Biophys Res Commun; 2013 Apr; 433(4):489-95. PubMed ID: 23528241 [TBL] [Abstract][Full Text] [Related]
6. Epigenetic silencing of the proapoptotic gene BIM in anaplastic large cell lymphoma through an MeCP2/SIN3a deacetylating complex. Piazza R; Magistroni V; Mogavero A; Andreoni F; Ambrogio C; Chiarle R; Mologni L; Bachmann PS; Lock RB; Collini P; Pelosi G; Gambacorti-Passerini C Neoplasia; 2013 May; 15(5):511-22. PubMed ID: 23633923 [TBL] [Abstract][Full Text] [Related]
7. Genome-wide DNA methylation as an epigenetic consequence of Epstein-Barr virus infection of immortalized keratinocytes. Birdwell CE; Queen KJ; Kilgore PC; Rollyson P; Trutschl M; Cvek U; Scott RS J Virol; 2014 Oct; 88(19):11442-58. PubMed ID: 25056883 [TBL] [Abstract][Full Text] [Related]
8. CpG methylation of the major Epstein-Barr virus latency promoter in Burkitt's lymphoma and Hodgkin's disease. Robertson KD; Manns A; Swinnen LJ; Zong JC; Gulley ML; Ambinder RF Blood; 1996 Oct; 88(8):3129-36. PubMed ID: 8874213 [TBL] [Abstract][Full Text] [Related]
9. EBV epigenetically suppresses the B cell-to-plasma cell differentiation pathway while establishing long-term latency. Styles CT; Bazot Q; Parker GA; White RE; Paschos K; Allday MJ PLoS Biol; 2017 Aug; 15(8):e2001992. PubMed ID: 28771465 [TBL] [Abstract][Full Text] [Related]
10. Epigenetic silencing of tumor suppressor genes during in vitro Epstein-Barr virus infection. Saha A; Jha HC; Upadhyay SK; Robertson ES Proc Natl Acad Sci U S A; 2015 Sep; 112(37):E5199-207. PubMed ID: 26324942 [TBL] [Abstract][Full Text] [Related]
11. Epigenetic histone modification of Epstein-Barr virus BZLF1 promoter during latency and reactivation in Raji cells. Murata T; Kondo Y; Sugimoto A; Kawashima D; Saito S; Isomura H; Kanda T; Tsurumi T J Virol; 2012 May; 86(9):4752-61. PubMed ID: 22357272 [TBL] [Abstract][Full Text] [Related]
12. CpG-methylation regulates a class of Epstein-Barr virus promoters. Bergbauer M; Kalla M; Schmeinck A; Göbel C; Rothbauer U; Eck S; Benet-Pagès A; Strom TM; Hammerschmidt W PLoS Pathog; 2010 Sep; 6(9):e1001114. PubMed ID: 20886097 [TBL] [Abstract][Full Text] [Related]
13. Histone Loaders CAF1 and HIRA Restrict Epstein-Barr Virus B-Cell Lytic Reactivation. Zhang Y; Jiang C; Trudeau SJ; Narita Y; Zhao B; Teng M; Guo R; Gewurz BE mBio; 2020 Oct; 11(5):. PubMed ID: 33109754 [TBL] [Abstract][Full Text] [Related]
14. Restricted TET2 Expression in Germinal Center Type B Cells Promotes Stringent Epstein-Barr Virus Latency. Wille CK; Li Y; Rui L; Johannsen EC; Kenney SC J Virol; 2017 Mar; 91(5):. PubMed ID: 28003489 [TBL] [Abstract][Full Text] [Related]
15. Epstein-barr virus-induced resistance to drugs that activate the mitotic spindle assembly checkpoint in Burkitt's lymphoma cells. Leao M; Anderton E; Wade M; Meekings K; Allday MJ J Virol; 2007 Jan; 81(1):248-60. PubMed ID: 17035311 [TBL] [Abstract][Full Text] [Related]
16. Role of the histone H3 lysine 9 methyltransferase Suv39 h1 in maintaining Epsteinn-Barr virus latency in B95-8 cells. Imai K; Kamio N; Cueno ME; Saito Y; Inoue H; Saito I; Ochiai K FEBS J; 2014 May; 281(9):2148-58. PubMed ID: 24588869 [TBL] [Abstract][Full Text] [Related]
17. Epigenetic repression of p16(INK4A) by latent Epstein-Barr virus requires the interaction of EBNA3A and EBNA3C with CtBP. Skalska L; White RE; Franz M; Ruhmann M; Allday MJ PLoS Pathog; 2010 Jun; 6(6):e1000951. PubMed ID: 20548956 [TBL] [Abstract][Full Text] [Related]
18. Repression of the proapoptotic cellular BIK/NBK gene by Epstein-Barr virus antagonizes transforming growth factor β1-induced B-cell apoptosis. Campion EM; Hakimjavadi R; Loughran ST; Phelan S; Smith SM; D'Souza BN; Tierney RJ; Bell AI; Cahill PA; Walls D J Virol; 2014 May; 88(9):5001-13. PubMed ID: 24554662 [TBL] [Abstract][Full Text] [Related]
19. Latent Epstein-Barr virus can inhibit apoptosis in B cells by blocking the induction of NOXA expression. Yee J; White RE; Anderton E; Allday MJ PLoS One; 2011; 6(12):e28506. PubMed ID: 22174825 [TBL] [Abstract][Full Text] [Related]
20. Interplay between the Epigenetic Enzyme Lysine (K)-Specific Demethylase 2B and Epstein-Barr Virus Infection. Vargas-Ayala RC; Jay A; Manara F; Maroui MA; Hernandez-Vargas H; Diederichs A; Robitaille A; Sirand C; Ceraolo MG; Romero-Medina MC; Cros MP; Cuenin C; Durand G; Le Calvez-Kelm F; Mundo L; Leoncini L; Manet E; Herceg Z; Gruffat H; Accardi R J Virol; 2019 Jul; 93(13):. PubMed ID: 30996097 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]